Table 141Evidence summary table: haloperidol versus ziprasidone – general adverse events

OutcomeStudiesParticipantsEffect EstimateI2Less with
Incidence of patients with AEs57,69,73,83,86,144614481.13 (1.03, 1.23)31%ziprasidone
Mortality116,14424083.10 (0.13, 75.68)NEND
Serious AEs57,86,91,144414031.02 (0.60, 1.75)0%ND
Withdrawals due to AEs57,83,86,91,116,144615511.73 (1.30, 2.32)0%ziprasidone

Significant results are in bold; AE = adverse event; I2 = I–squared; ND = no difference; NE = not estimable

From: Appendix N, Summary Tables of Adverse Events

Cover of First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness
First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness [Internet].
Comparative Effectiveness Reviews, No. 63.
Abou-Setta AM, Mousavi SS, Spooner C, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.